Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Rebald AB
AB
Active
Org 5593241291
Medical specialists activities · NACE 8622
Est. 2021
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 194K
EBITDA margin
99.4%
+2726% vs 2024
Equity ratio
99.6%
Financial strength
Net profit 2025
SEK -1K
+87% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 194K
—
EBITDA
SEK 193K
+2726%
Net profit
SEK -1K
+87%
Total assets
SEK 16K
-7%
Equity
SEK 16K
-7%
Employees
1
—
Company information
Legal name
Rebald AB
Org number
5593241291
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
24 juni 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-05-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bedriver medicinsk vård samt kapitalförvaltning och där med förenlig verksamhet.
Contact
Address
Email
rebeccas_89@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Göteborg
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2022
2023
2024
2025
Revenue
192
194
0
194
Staff expenses
−17
−272
−0
—
EBITDA
132
−109
−7
193
Depreciation & amort.
—
—
—
—
EBIT
132
−109
−7
−1
Net financials
—
−0
−2
—
Profit before tax
132
−109
−9
−1
Tax
−27
—
—
—
Net profit
105
−109
−9
−1
Balance sheet
SEK thousands
Item
2022
2023
2024
2025
Total assets
205
97
18
16
Equity
130
21
18
16
Long-term debt
—
—
—
—
Short-term debt
75
76
0
0
Total debt
75
76
0
0
Financial ratios
5-year trend
EBITDA margin
99.4%
This company
15.8%
Market median
+529% vs market
2022
2025
Equity ratio
99.6%
This company
38.2%
Market median
+161% vs market
2022
2025
Return on equity
-7.6%
This company
18.4%
Market median
-141% vs market
2022
2025
Net profit margin
-0.6%
This company
8.1%
Market median
-107% vs market
2022
2025
Asset turnover
11.76×
This company
1.12×
Market median
+950% vs market
2022
2025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2022
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-06-01 – 2025-05-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-06-01 – 2024-05-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-06-01 – 2023-05-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-06-24 – 2022-05-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
AR
Anna Rebecka Linn Aldorsson
Board of Directors
2022
CD
Carina Deborah Kask
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Rebald AB also hold positions in
0
other companies.
Person
Role here
Other companies
Anna Rebecka Linn Aldorsson
Board of Directors
0 companies
Carina Deborah Kask
Deputy Board Member
0 companies